Abstract
Immediate β2-integrin activation upon T cell receptor stimulation is critical for effective interaction between T cells and their targets and may therefore be used for the rapid identification and isolation of functional T cells. We present a simple and sensitive flow cytometry-based assay to assess antigen-specific T cells using fluorescent intercellular adhesion molecule (ICAM)-1 multimers that specifically bind to activated β2-integrins. The method is compatible with surface and intracellular staining; it is applicable for monitoring of a broad range of virus-, tumor-, and vaccine-specific CD8+ T cells, and for isolating viable antigen-reacting cells. ICAM-1 binding correlateswith peptide-MHCmultimer binding but, notably, it identifies the fraction of antigen-specific CD8+ T cells with immediate and high functional capability (i.e., expressing high levels of cytotoxic markers and cytokines). Compared with the currently available methods, staining of activated β2-integrins presents the unique advantage of requiring activation times of only several minutes, therefore delivering functional information nearly reflecting the in vivo situation. Hence, the ICAM-1 assay is most suitable for rapid and precise monitoring of functional antigen-specific T cell responses, including for patient samples in a variety of clinical settings, as well as for the isolation of functional T cells for adoptive cell-transfer immunotherapies.
| Original language | English |
|---|---|
| Journal | Proceedings of the National Academy of Sciences of the United States of America |
| Volume | 115 |
| Issue number | 24 |
| Pages (from-to) | E5536-E5545 |
| ISSN | 0027-8424 |
| DOIs | |
| Publication status | Published - 12.06.2018 |
Funding
ACKNOWLEDGMENTS. We thank S. Stevanovićfor providing synthetic peptides; S. Heidu, J. Lehnholz, K. Witte, and E.-M. Schmidt for excellent technical assistance and advice; M. Szczepanski, J. C. P. Santiago, M. Esen, M. Buhl, and G. Marasca for sampling blood from the subjects and patients; all subjects and patients who participated in this study; and M. Hallschmid and R. Littwin for critical reading and proofreading of the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft Grants SFB 654 (to T.L. and H.-G.R.) and SFB 685 (to C.G. and H.-G.R.); grants from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD; 01GI0925) (to S.D. and J.B.); and European Research Council Grant AdG 339842, MUTAEDITING (to H.-G.R.).
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)